检验医学 ›› 2023, Vol. 38 ›› Issue (11): 1101-1105.DOI: 10.3969/j.issn.1673-8640.2023.11.018
收稿日期:
2022-04-27
修回日期:
2022-12-16
出版日期:
2023-11-30
发布日期:
2024-01-10
通讯作者:
贾雄飞,E-mail:作者简介:
田媛媛,女,1982年生,学士,主管技师,主要从事临床微生物检验工作。
Received:
2022-04-27
Revised:
2022-12-16
Online:
2023-11-30
Published:
2024-01-10
摘要:
肠球菌是革兰阳性兼性厌氧球菌,主要分布在宿主肠道,生殖道或口腔中也有少量存在。临床常见菌属为粪肠球菌和屎肠球菌。肠球菌作为共生菌,在人类和动物的消化系统定植,并参与免疫调节。一直以来,肠球菌主要用于益生菌食品添加剂,或辅助治疗肠道菌群失调。然而,肠球菌可能因其毒力和多重耐药变化导致临床感染,也是一种条件致病菌。肠球菌可从胃肠道转移到其他组织和器官,其毒力和耐药性是影响感染治疗的危险因素。肠球菌基因组可塑性相关研究预测其有变异为致病菌的可能性。文章对肠球菌的有益性和致病性进行综述。
中图分类号:
田媛媛, 贾雄飞. 肠球菌的有益性和致病性[J]. 检验医学, 2023, 38(11): 1101-1105.
TIAN Yuanyuan, JIA Xiongfei. Advantages and pathogenicity of Enterococci[J]. Laboratory Medicine, 2023, 38(11): 1101-1105.
[1] |
FRANZ C M, HUCH M, ABRIOUEL H, et al. Enterococci as probiotics and their implications in food safety[J]. Int J Food Microbiol, 2011, 151(2):125-140.
DOI URL |
[2] | BEN BRAÏEK O, SMAOUI S. Enterococci:between emerging pathogens and potential probiotics[J]. Biomed Res Int, 2019, 23:5938210. |
[3] |
THOMAS A M, SEGATA N. Multiple levels of the unknown in microbiome research[J]. BMC Biol, 2019, 17(1):48.
DOI PMID |
[4] | GARCÍA-SOLACHE M, RICE L B. The Enterococcus:a model of adaptability to its environment[J]. Clin Microbiol Rev, 2019, 32(2):e00058. |
[5] |
QIN J, LI R, RAES J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285):59-65.
DOI |
[6] |
ZHOU B, YUAN Y, ZHANG S, et al. Intestinal flora and disease mutually shape the regional immune system in the intestinal tract[J]. Front Immunol, 2020, 11:575.
DOI PMID |
[7] |
POPOVIĆ N, DJOKIĆ J, BRDARIĆ E, et al. The influence of heat-killed Enterococcus faecium BGPAS1-3 on the tight junction protein expression and immune function in differentiated caco-2 cells infected with Listeria monocytogenes ATCC 19111[J]. Front Microbiol, 2019, 10:412.
DOI URL |
[8] | TARASOVA E, YERMOLENKO E, DONETS V, et al. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics[J]. Benef Microbe, 2010, 1(3):265-270. |
[9] |
XU H, HUANG W, HOU Q, et al. Oral administration of compound probiotics improved canine feed intake,weight gain,immunity and intestinal microbiota[J]. Front immunol, 2019, 10:666.
DOI URL |
[10] |
WU Y, ZHOU W, GENG Y, et al. Effects of dietary Enterococcus faecium NCIMB 11181 supplementation on growth performance and cellular and humoral immune responses in broiler chickens[J]. Poult Sci, 2019, 98(1):150-163.
DOI URL |
[11] |
MEGO M, KONCEKOVA R, MIKUSKOVA E, et al. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase Ⅱ study[J]. Support Care Cancer, 2006, 14(3):285-290.
DOI URL |
[12] |
GÚTIEZ L, BORRERO J, JIMÉNEZ J J, et al. Genetic and biochemical evidence that recombinant Enterococcus spp. strains expressing gelatinase(GelE)produce bovine milk-derived hydrolysates with high angiotensin converting enzyme-inhibitory activity(ACE-IA)[J]. J Agric Food Chem, 2014, 62(24):5555-5564.
DOI URL |
[13] |
TARANGO-HERNANDEZ S, ALARCON-ROJO A D, ROBLES-SANCHEZ M, et al. Short communication:potential of fresco-style cheese whey as a source of protein fractions with antioxidant and angiotensin-i-converting enzyme inhibitory activities[J]. J Dairy Sci, 2015, 98(11):7635-7639.
DOI URL |
[14] |
GIROMINI C, FEKETE Á A, GIVENS D I, et al. Short-communication:a comparison of the in vitro angiotensin-1-converting enzyme inhibitory capacity of dairy and plant protein supplements[J]. Nutrients, 2017, 9(12):1352.
DOI URL |
[15] | CRYAN J F, DINAN T G. Mind-altering microorganisms:the impact of the gut microbiota on brain and behaviour[J]. Nat Rev Neurosci, 2012, 13(10):701-712. |
[16] |
RIBEIRO S, DOMINGOS-LOPES M F P, TANTON C, et al. Production of γ-aminobutyric acid(GABA)by Lactobacillus otakiensis and other Lactobacillus sp. isolated from traditional Pico cheese[J]. Intern J Dairy Technol, 2018, 71(4):11.
DOI URL |
[17] |
SOLOMON F B, WADILO F W, AROTA A A, et al. Antibiotic resistant airborne bacteria and their multidrug resistance pattern at university teaching referral hospital in South Ethiopia[J]. Ann Clin Microbiol Antimicrob, 2017, 16(1):29.
DOI URL |
[18] |
AL-BALAWI M, MORSY F M. Enterococcus faecalis is a better competitor than other lactic acid bacteria in the initial colonization of colon of healthy newborn babies at first week of their life[J]. Front Microbiol, 2020, 11:2017.
DOI URL |
[19] | BONACINA J, SUÁREZ N, HORMIGO R, et al. A genomic view of food-related and probiotic Enterococcus strains[J]. DNA Res, 2017, 24(1):11-24. |
[20] |
RYU B H, HONG J, JUNG J, et al. Clinical characteristics and treatment outcomes of Enterococcus durans bacteremia:a 20-year experience in a tertiary care hospital[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(9):1743-1751.
DOI |
[21] |
TENDOLKAR P M, BAGHDAYAN A S, SHANKAR N. Pathogenic Enterococci:new developments in the 21st century[J]. Cell Mol Life Sci, 2003, 60(12):2622-2636.
DOI URL |
[22] | KRAWCZYK B, SAMET A, BRONK M, et al. Emerging linezolid-resistant,vancomycin resistant Enterococcus faecium from a patient of a haematological unit in Poland[J]. Pol J Microbiol, 2004, 53(3):193-196. |
[23] |
BRETÓN J R, PESET V, MORCILLO F, et al. Neonatal meningitis due to Enterococcus spp.:presentation of four cases[J]. Enferm Infecc Microbiol Clin, 2002, 20(9):443-447.
DOI URL |
[24] |
KRAMER A, SCHWEBKE I, KAMPF G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review[J]. Bmc Infect Dis, 2006, 6(1):130.
DOI URL |
[25] | O'BRIEN V P, HANNAN T J, NIELSEN H V, et al. Drug and vaccine development for the treatment and prevention of urinary tract infections[J]. Microbiol Spectr, 2016, 4(1):10. |
[26] |
FINE R L, VIEIRA S M, GILMORE M S, et al. Mechanisms and consequences of gut commensal translocation in chronic diseases[J]. Gut Microbes, 2019, 11(2):217-230.
DOI URL |
[27] |
ZENG J, TENG F, WEINSTOCK G M, et al. Translocation of Enterococcus faecalis strains across a monolayer of polarized human enterocyte-like T84 cells[J]. J Clinic Microbiol, 2004, 42(3):1149-1154.
DOI URL |
[28] |
KNOOP K A, MCDONALD K G, KULKARNI D H, et al. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria[J]. Gut, 2016, 65(7):1100-1109.
DOI PMID |
[29] |
MANFREDO VIEIRA S, HILTENSPERGER M, KUMAR V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans[J]. Science, 2018, 359(6380):1156-1161.
DOI PMID |
[30] |
SZEMIAKO K, KRAWCZYK B, SAMET A, et al. A subset of two adherence systems,acute pro-inflammatory pap genes and invasion coding dra,fim,or sfa,increases the risk of Escherichia coli translocation to the bloodstream[J]. Eur J Clin Microbiol Infect Dis, 2013, 32(12):1579-1582.
DOI URL |
[31] | ESCOLÀ-VERGÉ L, PEGHIN M, GIVONE F, et al. Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis:results of an observational multicenter study[J]. Rev Esp Cardiol(Engl Ed), 2020, 73(9):711-717. |
[32] |
ARCHAMBAUD C, DERRÉ-BOBILLOT A, LAPAQUE N, et al. Intestinal translocation of Enterococci requires a threshold level of enterococcal overgrowth in the lumen[J]. Sci Rep, 2019, 9(1):8926.
DOI |
[33] |
WANG X, ALLEN T D, MAY R J, et al. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect[J]. Cancer Res, 2008, 68(23):9909-9917.
DOI URL |
[34] |
REZASOLTANI S, ASADZADEH AGHDAEI H, DABIRI H, et al. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer[J]. Microb Pathogen, 2018, 124:244-249.
DOI URL |
[35] |
CHENG Y, LING Z, LI L, et al. The intestinal microbiota and colorectal cancer[J]. Front Immun, 2020, 11:615056.
DOI URL |
[36] | AGUDELO HIGUITA N I, HUYCKE M M. Enterococcal disease, epidemiology, and implications for treatment-Enterococci:from commensals to leading causes of drug resistant infection[J]. Massachus Eye and Ear Infirm, 2014. |
[37] | NIYAZI D, MICHEVA I, STOEVA T. Bacterial and fungal complications in patients undergoing hematopoietic stem cell transplantation[J]. Clinic Transf Haematol, 2020, 56(1-2):27-31. |
[38] |
ROBBINS W C, TOMPSETT R. Treatment of enterococcal endocarditis and bacteremia;results of combined therapy with penicillin and streptomycin[J]. Am J Med, 1951, 10(3):278-299.
PMID |
[39] |
HEGSTAD K, MIKALSEN T, COQUE T M, et al. Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium[J]. Clin Microbiol Infect, 2010, 16(6):541-554.
DOI URL |
[40] |
PETRIN S, PATUZZI I, CESARE A D, et al. Evaluation and quantification of antimicrobial residues and antimicrobial resistance genes in two Italian swine farms[J]. Enviro Pollut, 2019, 255:113183.
DOI URL |
[41] |
RIPATTI S, TIKKANEN E, ORHO-MELANDER M, et al. A multilocus genetic risk score for coronary heart disease:case-control and prospective cohort analyses[J]. Lancet, 2010, 376(9750):1393-1400.
DOI URL |
[42] | TIAN Y, YU H, WANG Z. Distribution of acquired antibiotic resistance genes among Enterococcus spp. isolated from a hospital in Baotou,China[J]. BMC Research Notes, 2019, 12(1). |
[43] |
KRAWCZYK B, WYSOCKA M, KOTOWSKI R, et al. Linezolid-resistant Enterococcus faecium strains isolated from one hospital in Poland-commensals or hospital-adapted pathogens?[J]. PLoS One, 2020, 15(5):e0233504.
DOI URL |
[44] |
LEBRETON F, MANSON A L, SAAVEDRA J T, et al. Tracing the Enterococci from paleozoic origins to the hospital[J]. Cell, 2017, 169(5):849-861.
DOI URL |
[45] | PALMER K L, GILMORE M S. Multidrug-resistant Enterococci lack CRISPR-cas[J]. mBio, 2010, 1(4):e00227. |
[46] | PRICE V J, HUO W, SHARIFI A, et al. CRISPR-Cas and restriction-modification act additively against conjugative antibiotic resistance plasmid transfer in Enterococcus faecalis[J]. mSphere, 2016, 1(3):e00064. |
[47] |
HIRT H, MANIAS D A, BRYAN E M, et al. Characterization of the pheromone response of the Enterococcus faecalis conjugative plasmid pCF10:complete sequence and comparative analysis of the transcriptional and phenotypic responses of pCF10-containing cells to pheromone induction[J]. J Bacteriol, 2005, 187(3):1044-1054.
DOI URL |
[48] |
KICHENARADJA P, SIGUIER P, PÉROCHON J, et al. ISbrowser:an extension of ISfinder for visualizing insertion sequences in prokaryotic genomes[J]. Nucleic Acids Res, 2010, 38:D62-D68.
DOI URL |
[1] | 郭兰芳, 郭燕, 郑永贵, 杨洋, 尹丹丹, 施清喻, 胡付品. 氨苄西林预报粪肠球菌和屎肠球菌亚胺培南敏感性的可行性研究[J]. 检验医学, 2022, 37(2): 150-154. |
[2] | 康怡, 朱宏, 沈瀚, 周万青. 临床血液和尿液样本分离肠球菌毒力基因分析[J]. 检验医学, 2022, 37(11): 1030-1033. |
[3] | 王婧婧, 吴林清, 陈如寿, 王玉丰. 耐万古霉素肠球菌耐药基因、转座子结构和多位点序列分析[J]. 检验医学, 2021, 36(9): 891-895. |
[4] | 吴思颖, 王晓庆, 刘山泉, 肖玉玲, 何超, 马莹, 谢轶, 康梅. MALDI-TOF MS快速鉴定耐万古霉素屎肠球菌及其流行病学分型性能分析[J]. 检验医学, 2020, 35(5): 470-475. |
[5] | 郭伟, 黄江华, 吴蓓, 陈芳, 何晓华. 某县医院肠球菌临床分离株耐药性及毒力基因携带情况分析[J]. 检验医学, 2020, 35(12): 1267-1271. |
[6] | 林贺, 薛苗, 汪怀周, 黄晓春, 秦阳华. 4株利奈唑胺不敏感粪肠球菌的23S rRNA基因突变分析[J]. 检验医学, 2018, 33(5): 452-456. |
[7] | 赵悦, 朱巍巍, 刘锦燕, 李文静, 王影, 史册, 项明洁. 无绿藻研究进展[J]. 检验医学, 2017, 32(10): 928-932. |
[8] | 方毅, 赵付菊, 张景皓, 赵虎. 痰标本中检出一例水生拉恩菌[J]. 检验医学, 2015, 30(7): 774-775. |
[9] | 张正银, 孙晴, 王立平. 2011至2013年临床分离肠球菌属细菌的耐药性变迁分析[J]. 检验医学, 2015, 30(2): 206-208. |
[10] | 鲍彩丽, 范倩燕, 吴迪, 汤园园, 谈秋雯, 张雪莲. 安图医院尿路感染患者中段尿中分离出的粪肠球菌和屎肠球菌的耐药性分析[J]. 检验医学, 2014, 29(1): 38-41. |
[11] | 喻茂文. 临床肠球菌分布及耐药性检测[J]. 检验医学, 2012, 27(6): 524-526. |
[12] | 潘虹霞;蔡波;孙景勇;倪语星. 3年间医院内肠球菌的检出及其耐药性监测情况分析[J]. 检验医学, 2009, 24(07): 541-544. |
[13] | 王惠姣;周益琴. 医院感染肠球菌的分布及耐药性分析[J]. 检验医学, 2009, 24(05): 401-402. |
[14] | 吕萍;徐樨巍;宋文琪;董方;杨永弘;沈叙庄. 儿童肠球菌多重耐药与Ⅰ类整合子的检测[J]. 检验医学, 2009, 24(03): 219-222. |
[15] | 王社梁;钱小毛. 肠球菌临床感染及其耐药性分析[J]. 检验医学, 2009, 24(01): 61-63. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||